Physicians
FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder
- Ultragenyx scored a belated regulatory win with FDA approval for a first-in-disease gene therapy, giving the company a boost after a previous regulatory rejection and a recent late-stage setback.
